Imunon Inc (IMNN)

Imunon Inc. is a clinical-stage biotechnology firm focused on pioneering immune-mediated therapies targeting cancer and infectious diseases. Utilizing its proprietary INFECT platform, the company seeks to amplify immune responses to facilitate effective tumor destruction. With a robust pipeline of therapeutics at various clinical stages and strategic partnerships enhancing its capabilities, Imunon is well-positioned to drive innovation in immunotherapy, potentially altering treatment paradigms and improving patient outcomes in the biopharmaceutical sector.